{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:01Z","timestamp":1790813941866,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swedish Government"},{"name":"County Councils","award":["ALFGBG-965885"],"award-info":[{"award-number":["ALFGBG-965885"]}]},{"name":"County Councils","award":["ALFGBG-71320"],"award-info":[{"award-number":["ALFGBG-71320"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The incidence and clinical relevance of asymptomatic cerebrospinal fluid escape (CSFE) during antiretroviral therapy (ART) is uncertain. We examined the impact and incidence of asymptomatic CSFE in a Swedish HIV cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Neuroasymptomatic people with HIV (PWH) who have been on ART for at least 6 months with suppressed plasma viral load were followed longitudinally. CSFE was defined as either increased CSF HIV-1 RNA with concurrent plasma suppression or CSF HIV-1 RNA exceeding that in plasma when both were quantifiable. Paired CSF and plasma were analyzed for HIV-1 RNA, neopterin, neurofilament light protein (NfL), white blood cell (WBC) count, and albumin ratio.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Asymptomatic CSFE (cutoff 50 copies\/mL) was found in 4 of 173 PWH (2%) and 5 of 449 samples (1%). The corresponding proportions were 8% of PWH and 4% for samples using a 20 copies\/mL cutoff for CSF HIV-1 RNA. CSFE samples (cutoff 20 copies\/mL) had a 25% higher geometric mean of CSF neopterin (P = .01) and 8% higher albumin ratio (P = .04) compared to samples without CSFE. No differences were observed in CSF NfL levels (P = .8). The odds ratio for increased CSF WBC (\u2265 3 cells\/\u03bcL) in samples with CSFE was 3.9 (P = .004), compared to samples without elevated CSF viral load.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Asymptomatic CSFE was identified in only 4 (2%) PWH, with no cases of continuous CSFE observed. Increased CSF HIV-1 RNA was associated with biomarkers of CNS immune activation and blood-brain barrier impairment, but not with biomarkers of neuronal injury.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae555","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:20:21Z","timestamp":1731068421000},"page":"e429-e437","source":"Crossref","is-referenced-by-count":9,"title":["Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences"],"prefix":"10.1093","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-9040","authenticated-orcid":false,"given":"Gustaf","family":"Ulfhammer","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-5828","authenticated-orcid":false,"given":"Aylin","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Mellgren","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Tyrberg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-7485","authenticated-orcid":false,"given":"Erik","family":"S\u00f6rstedt","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-2324","authenticated-orcid":false,"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1532-5177","authenticated-orcid":false,"given":"Johanna","family":"Gostner","sequence":"additional","affiliation":[{"name":"Institute of Medical Biochemistry, Biocenter, Innsbruck Medical University , Innsbruck ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-9563","authenticated-orcid":false,"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Institute of Biological Chemistry, Biocenter, Innsbruck Medical University , Innsbruck ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital , M\u00f6lndal ,","place":["Sweden"]},{"name":"Department of Neurodegenerative Disease, Institute of Neurology, University College London , London ,","place":["United Kingdom"]},{"name":"UK Dementia Research Institute , University College London, London ,","place":["United Kingdom"]},{"name":"Hong Kong Center for Neurodegenerative Diseases , Hong Kong ,","place":["China"]},{"name":"Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison , Madison, Wisconsin ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Nystr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-9981","authenticated-orcid":false,"given":"Arvid","family":"Ed\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital , Gothenburg ,","place":["Sweden"]},{"name":"Public Health Agency of Sweden , Solna ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2025022016333778900_jiae555-B1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"Valcour","year":"2012","journal-title":"J Infect Dis"},{"key":"2025022016333778900_jiae555-B2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2334-5-98","article-title":"Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment","volume":"5","author":"Spudich","year":"2005","journal-title":"BMC Infect Dis"},{"key":"2025022016333778900_jiae555-B3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/cid\/ciab943","article-title":"Cerebrospinal fluid viral load across the spectrum of untreated human immunodeficiency virus type 1 (HIV-1) infection: a cross-sectional multicenter study","volume":"75","author":"Ulfhammer","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025022016333778900_jiae555-B4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00042560-199804010-00001","article-title":"Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study","volume":"17","author":"Gissl\u00e9n","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"Suppl 3","key":"2025022016333778900_jiae555-B5","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1086\/533419","article-title":"Antiretroviral therapy and central nervous system HIV type 1 infection","volume":"197","author":"Price","year":"2008","journal-title":"J Infect Dis"},{"key":"2025022016333778900_jiae555-B6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/jnnp-2012-304022","article-title":"HIV, dementia and antiretroviral drugs: 30 years of an epidemic","volume":"84","author":"Manji","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025022016333778900_jiae555-B7","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"2025022016333778900_jiae555-B8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the EuroSIDA cohort","volume":"55","author":"d'Arminio Monforte","year":"2004","journal-title":"Ann Neurol"},{"key":"2025022016333778900_jiae555-B9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11904-015-0267-7","article-title":"Cerebrospinal fluid HIV Escape from antiretroviral therapy","volume":"12","author":"Ferretti","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025022016333778900_jiae555-B10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025022016333778900_jiae555-B11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0000000000002074","article-title":"Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects","volume":"33","author":"Perez-Valero","year":"2019","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/infdis\/jiw454","article-title":"Asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: a longitudinal study","volume":"214","author":"Eden","year":"2016","journal-title":"J Infect Dis"},{"key":"2025022016333778900_jiae555-B13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2055-6640(20)30879-7","article-title":"Highlights of the global HIV-1 CSF Escape consortium meeting, 9 June 2016, Bethesda, MD, USA","volume":"2","author":"Joseph","year":"2016","journal-title":"J Virus Erad"},{"issue":"Suppl 2","key":"2025022016333778900_jiae555-B14","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1097\/QAD.0000000000002253","article-title":"What can characterization of cerebrospinal fluid escape populations teach US about viral reservoirs in the central nervous system?","volume":"33","author":"Joseph","year":"2019","journal-title":"AIDS"},{"issue":"Suppl 2","key":"2025022016333778900_jiae555-B15","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/QAD.0000000000002252","article-title":"Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS","volume":"33","author":"Winston","year":"2019","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cyto.2016.04.004","article-title":"CSF\/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF","volume":"83","author":"Nightingale","year":"2016","journal-title":"Cytokine"},{"key":"2025022016333778900_jiae555-B17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1086\/657342","article-title":"HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment","volume":"202","author":"Eden","year":"2010","journal-title":"J Infect Dis"},{"key":"2025022016333778900_jiae555-B18","first-page":"15","article-title":"CSF inflammation markers associated with asymptomatic viral escape in cerebrospinal fluid of HIV-positive individuals on antiretroviral therapy","volume":"16","author":"Guha","year":"2023","journal-title":"Viruses"},{"issue":"Suppl 2","key":"2025022016333778900_jiae555-B19","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/QAD.0000000000002251","article-title":"The impact of HIV central nervous system persistence on pathogenesis","volume":"33","author":"Brew","year":"2019","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/cid\/ciy1066","article-title":"Human immunodeficiency virus type 1 RNA detected in the central nervous system (CNS) after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells","volume":"69","author":"Joseph","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025022016333778900_jiae555-B21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/jon.12552","article-title":"Brain MRI features of CSF human immunodeficiency virus escape","volume":"28","author":"Narvid","year":"2018","journal-title":"J Neuroimaging"},{"key":"2025022016333778900_jiae555-B22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","article-title":"Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load","volume":"26","author":"Peluso","year":"2012","journal-title":"AIDS"},{"issue":"Suppl 2","key":"2025022016333778900_jiae555-B23","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/QAD.0000000000002266","article-title":"Symptomatic cerebrospinal fluid escape","volume":"33","author":"Mastrangelo","year":"2019","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B24","doi-asserted-by":"crossref","first-page":"e0236162","DOI":"10.1371\/journal.pone.0236162","article-title":"Herpes zoster in HIV-1 infection: the role of CSF pleocytosis in secondary CSF escape and discordance","volume":"15","author":"Hagberg","year":"2020","journal-title":"PLoS One"},{"key":"2025022016333778900_jiae555-B25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s13365-016-0448-1","article-title":"Discordant CSF\/plasma HIV-1 RNA in patients with unexplained low-level viraemia","volume":"22","author":"Nightingale","year":"2016","journal-title":"J Neurovirol"},{"key":"2025022016333778900_jiae555-B26","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1097\/QAD.0000000000002992","article-title":"The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series","volume":"35","author":"Chan","year":"2021","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/QAI.0000000000003189","article-title":"Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study","volume":"93","author":"Filippidis","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025022016333778900_jiae555-B28","doi-asserted-by":"crossref","first-page":"e070693","DOI":"10.1136\/bmjopen-2022-070693","article-title":"Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid\u2014the Gothenburg HIV CSF study cohort","volume":"13","author":"Hagberg","year":"2023","journal-title":"BMJ Open"},{"key":"2025022016333778900_jiae555-B29","author":"European AIDS Clinical Society"},{"key":"2025022016333778900_jiae555-B30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":"Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection","volume":"7","author":"Hagberg","year":"2010","journal-title":"AIDS Res Ther"},{"key":"2025022016333778900_jiae555-B31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/pterid-2014-0015","article-title":"Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors","volume":"26","author":"Geisler","year":"2015","journal-title":"Pteridines"},{"key":"2025022016333778900_jiae555-B32","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","article-title":"Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls","volume":"17","author":"Yilmaz","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2025022016333778900_jiae555-B33","doi-asserted-by":"crossref","first-page":"e0242710","DOI":"10.1371\/journal.pone.0242710","article-title":"Longitudinal trends and determinants of patient-reported side effects on ART-a Swedish national registry study","volume":"15","author":"Mellgren","year":"2020","journal-title":"PLoS One"},{"key":"2025022016333778900_jiae555-B34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/QAI.0b013e31815ace97","article-title":"Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy","volume":"47","author":"Yilmaz","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025022016333778900_jiae555-B35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-10-62","article-title":"Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy","volume":"10","author":"Yilmaz","year":"2013","journal-title":"J Neuroinflammation"},{"key":"2025022016333778900_jiae555-B36","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/QAD.0000000000001950","article-title":"Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment","volume":"32","author":"Ulfhammer","year":"2018","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/135965350601100707","article-title":"Cerebrospinal fluid viral loads reach less than 2 copies\/ml in HIV-1-infected patients with effective antiretroviral therapy","volume":"11","author":"Yilmaz","year":"2006","journal-title":"Antivir Ther"},{"key":"2025022016333778900_jiae555-B38","doi-asserted-by":"crossref","first-page":"e0157160","DOI":"10.1371\/journal.pone.0157160","article-title":"Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment","volume":"11","author":"Eden","year":"2016","journal-title":"PLoS One"},{"key":"2025022016333778900_jiae555-B39","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","article-title":"Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation","volume":"28","author":"Dahl","year":"2014","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B40","doi-asserted-by":"crossref","first-page":"e88591","DOI":"10.1371\/journal.pone.0088591","article-title":"Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients","volume":"9","author":"Jessen Krut","year":"2014","journal-title":"PLoS One"},{"key":"2025022016333778900_jiae555-B41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s13365-015-0333-3","article-title":"Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders","volume":"21","author":"McGuire","year":"2015","journal-title":"J Neurovirol"},{"key":"2025022016333778900_jiae555-B42","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/QAD.0000000000002980","article-title":"Increased immune activation and signs of neuronal injury in HIV-negative people on preexposure prophylaxis","volume":"35","author":"Robertson","year":"2021","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B43","doi-asserted-by":"crossref","first-page":"ofx108","DOI":"10.1093\/ofid\/ofx108","article-title":"High cellular monocyte activation in people living with human immunodeficiency virus on combination antiretroviral therapy and lifestyle-matched controls is associated with greater inflammation in cerebrospinal fluid","volume":"4","author":"Booiman","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2025022016333778900_jiae555-B44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13365-020-00828-1","article-title":"Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape","volume":"26","author":"de Almeida","year":"2020","journal-title":"J Neurovirol"},{"key":"2025022016333778900_jiae555-B45","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/cid\/ciy267","article-title":"Impact of antiretroviral regimens on cerebrospinal fluid viral Escape in a prospective multicohort study of antiretroviral therapy-experienced human immunodeficiency virus-1-infected adults in the United States","volume":"67","author":"Mukerji","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025022016333778900_jiae555-B46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"key":"2025022016333778900_jiae555-B47","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1212\/NXI.0000000000000300","article-title":"Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV","volume":"3","author":"Anesten","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025022016333778900_jiae555-B48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/QAD.0000000000001779","article-title":"Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials","volume":"32","author":"White","year":"2018","journal-title":"AIDS"},{"key":"2025022016333778900_jiae555-B49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2334-12-100","article-title":"HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability","volume":"12","author":"Ruelle","year":"2012","journal-title":"BMC Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae555\/60801197\/jiae555.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/2\/e429\/60801197\/jiae555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/2\/e429\/60801197\/jiae555.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T16:34:19Z","timestamp":1740069259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/2\/e429\/7896343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2025,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae555","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2,15]]},"published":{"date-parts":[[2024,11,12]]}}}